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BACKGROUND: Sleep deprivation is strongly associated with cardiovascular disease (CVD) via sympathetic overstimulation and systemic 
inflammation in general population. However, the 
significance of poor sleep quality in chronic kidney disease 
(CKD) is still underexplored.
METHODS: This study assessed the sleep quality of 
39 with non-dialysis CKD (ND CKD) patients and 25 
hemodialysis CKD (HD CKD) patients using the Pittsburgh 
Sleep Quality Index (PSQI) questionnaire. Poor sleeper was 
defined as individual with PSQI > 5. 
RESULTS: The prevalence of poor sleeper (30% vs. 60%, 
p=0.029) and the cummulative PSQI (ND CKD 4.5±4.4, HD 
CKD 8±6,  p=0.038)  are  different  between  ND  CKD  and 
HD CKD groups. Among the ND CKD, there are association 
between short sleep duration (< 5 hours per day) with 
elevated diastolic blood pressure groups (r=0.421, p<0.05); 
habitual sleep efficiency with platelet-to-lymphocyte ratio 
(r= 0.532, p<0.0001); daytime dysfunction with increased 
hs-CRP (r=0.345, p=0.032) and neutrophil-to-lymphocyte 
ratio (r=0.320, p=0.046). In HD CKD group, a requirement 
to use sleep medication was associated with elevated high-
sensitivity C-reactive protein (hs-CRP) level (r=0.434, 
p=0.030) and decreased monocyte-to-lymphocyte ratio (r=-
0.410, p=0.042); daytime dysfunction was associated with 
serum hs-CRP (r=0.452, p=0.023).
CONCLUSION: This study revealed that some features 
of poor sleep quality in CKD patients including low sleep 
efficiency, daytime dysfunction and requirement to use sleep 
medication were associated with increased diastolic blood 
pressure, hs-CRP and blood-count-based inflammatory 
predictors. Thus, this finding prompt to pay closer attention 
to sleep complaints in the management of CVD risk factors 
in CKD patients.
KEywORDS:  sleep  quality, chronic  kidney  disease, 
blood pressure, inflammation
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Introduction
 Chronic kidney disease (CKD) is a progressive disease 
with high incidence and mortality rate.(1,2) The decreased 
kidney function in CKD stems from the progressive 
glomerular damage that is caused by the maladaptive 
response of functional kidney resident cells toward 
various stress including inflammation, oxidative stress 
and hypertension.(3,4) The mortality risk of an individual 
with CKD is increased along with CKD progressivity and 
strongly associated with cardiovascular risk factors such as 
inflammation and stress oxidative.(5)
 Sleep deprivation is a commonly observed condition 
which may associate with cardiovascular disease.(6) Sleep 
deprivation  is  experienced  by  approximately  15-25% 
of USA population and related to diastolic ventricular 
dysfunction, hypertension, coronary heart disease as well 
as conditions requiring heart-pacing.(6) The mechanisms 
in which sleep deprivation associated with cardiovascular 
disease (CVD) are sympathetic overstimulation and 
systemic inflammation. 
 During normal sleep, markedly different brain 
activity oscillates between two stages known rapid eye 
movement (REM) sleep and non-REM (NREM) sleep. 
During the NREM sleep, decreased sympathetic activity 
and activated vagal tone are responsible for the nocturnal 
dipping of blood pressure associated with sleep.(7) Sleep 
loss and  sleep  disorders  lead  to  sympathetic  nervous 
system stimulation and attenuation of the sleep-induced 
decrease in blood pressure.(7) Increased plasma renin 
activity has been observed in the non-CKD population with 
sleep deprivation and directly affected blood pressure by 
triggering vasoconstriction.(8)
 Furthermore, increased plasma level of pro-
inflammatory cytokines has also been found in individuals 
with sleep deprivation and sleep fragmentation.(9) Elevated 
plasma level of pro-inflammatory cytokines such as 
C-reactive protein (CRP) and interleukin (IL)-6  were 
associated with endothelial dysfunction and atherosclerotic 
disease.(10) Although numerous studies have reported the 
association between poor sleep quality and CVD in the 
general population, the interaction of sleep quality and 
CVD risk factors among individuals with CKD is still 
underexplored.
 Since sleep deprivation in general population correlates 
well with increased risk of CVD (6), it is important to study 
whether sleep quality also affects the CVD risk factors 
among CKD population. This study evaluated components 
that determine the quality of sleep in both hemodialysis 
CKD (HD CKD) and non-dialysis CKD (ND CKD) patients 
using commonly used questionnaire Pittsburgh Sleep 
Quality Index (PSQI). The questionnaire evaluates several 
sleep quality components including subjective sleep quality, 
sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleeping medications and daytime 
dysfunction. This study aimed to investigate the association 
of those determiners of sleep quality with inflammation 
marker high sensitivity CRP (hs-CRP) and other blood-
count-based inflammatory predictors which correlated 
well with cardiovascular outcomes, such as lymphocyte-
to-monocyte, platelet-to-lymphocyte and neutrophil-
to-lymphocyte ratios.(11) The study also investigated 
the association between sleep quality components with 
blood pressure and obesity as a factor that modulates the 
occurrence of sleep disturbance.
Methods
Study Design and Participant
This investigation is part of Airlangga University’s 
study in validating score-based assessment tools for 
malnutrition, inflammation and oxidative stress. This study 
is an observational study with a cross-sectional design, 
constitutively enrolled stage II to V CKD patients who 
visited a government and a private hospital in Surabaya, 
Indonesia on May to August 2017. The study includes 64 
participants agreed and gave their consent for sleep quality 
assessment. The diagnosis of CKD was confirmed by The 
National Kidney Foundation Kidney Disease Outcomes 
Quality Initiative (NKF K-DOQI) criteria based on Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation (estimated glomerular filtration rate (eGFR) ≤ 60 
mL/min/1.73 m2, urine albumin > 300 mg/day, Albumin 
to Creatinine Ratio > 250 mg/g for men and > 355 mg/g 
for women). The subjects who had an overt infection, 
malignancy, and fever in the last three days were excluded 
from this study. The study was approved by Airlangga 
University Hospital Ethics Committee (Approval number: 
093/IGH/2017) and conducted by a research team with 
Good Clinical Practice certification.
Sleep Quality Assessment
In this study, the trained examiners interviewed the study 
participants based on the PSQI questionnaire as previously 
explained.(12) The PSQI questionnaire is an instrument 
to assess the sleep quality by measuring seven areas or 
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components: subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, use 
of sleeping medications and daytime dysfunction over the 
last month. This instrument can distinguish between “poor 
sleeper” and good sleeper”. Poor sleeper was defined as 
PSQI Score > 5. 
Laboratory Examination
Participants underwent blood and urine sampling early in the 
morning. Serum creatinine, serum cystatin-C, and complete 
blood count were measured based on established laboratory 
method previously explained. This study used hs-CRP for 
the inflammatory biomarker. The hs-CRP is measured in 
serum using enzyme-linked immunosorbent assay (Roche 
Diagnostic, CA, USA). 
Anthropometry and Blood Pressure Measurement
Anthropometric examination in this study was done to 
obtain a data of body weight, neck circumference, body 
mass index (BMI) and body fat percentage (BFP). Body 
weight was measured to the nearest 0.1 kg in balance-beam 
scale. The BFP was measured and calculated as described in 
the previous study.(13)
 All blood pressure measurement was performed 
by trained examiner utilizing a standard stethoscope and 
sphygmomanometer. Resting blood pressure was measured 
in a situated position by auscultation utilizing the Riva-
Rocci-Korotkoff technique following 5 minutes of rest. 
Systolic and diastolic blood pressure were controlled by the 
beginning and vanishing of the Korotkoff sounds (K1 and 
Characteristics of Study Participants
 Among 64 participants, 39  of them were ND CKD 
patients and 25 participants were HD CKD patients. There 
were significant differences in the proportion of poor 
sleepers (30% in ND CKD, 60% in HD CKD, p=0.029, 
Table 1) as well as cumulative PSQI (ND CKD 4.5±4.4, HD 
CKD 8±6, p=0.038, Figure 1) between the twogroups. 
Results
Data are expressed in Mean±SD or Median (Interquartile range). p<0.05 was considered 
significant. eGFR: estimated glomerular filtration rate; ACR: albumin to creatinine 
ratio; hs-CRP: high sensitivity C-reactive protein; BMI: body mass index; BFP: Body 
fat percentage; NS: not significant.
Characteristic ND CKD(n=39)
HD CKD
(n=25) p -value
Age (years) 58.6±5.3 57.8±10.9 NS
Sex ratio (F/M) 14/25 12/13 NS
eGFR (mL/minute/1.73 m2) 42±26 3±1 <0.0001
Urine ACR 184 (12-990) 1783 (715-3548) <0.0001
Serum creatinine (mg/dL) 1.8 (1.2-2.5) 14.0 (11.2-15.9) <0.0001
Serum cystatin-C (mg/L) 1.7 (1.2-2.6) 7.5 (6.5-7.9) <0.0001
hs-CRP (mg/L) 2.8 (0.4-13.9) 6.7 (0.6-36) 0.005
Poor sleeper, n (%) 12 (30) 15 (60) 0.029
Body weight (kg) 70.3±12.5 64.2±14.9 0.045
BMI 26.±4.2 25.1±4.5 NS
BFP (%) 20.9±7.5 19.0±7.8 NS
Table 1. Characteristics of study participants.
K5), individually. Proper cuff sizes were chosen by the upper 
right arm boundary by alluding to procedural guidelines. 
Three BP readings were taken at 2-minute interims. The 
least measurement result was utilized in the analysis.
Statistical Analysis
All quantitative data were subject to normality test using 
the Saphiro-Wilk method. Normally distributed values 
were described as mean and standard deviation (SD) and 
not normally distributed values were stated as median 
(interquartile range). Difference between groups of normally 
distributed interval data was assessed using unpaired T-test, 
while the Mann-Whitney test was used in not-normally 
distributed interval data. The difference of proportion 
between groups in this study is compared using the Chi-
square test.  All comparison test utilized in this study used 
two-tailed 95% confidence onterval. A significant difference 
was defined if the p<0.05. Data analysis is supported by 
XLSTAT version 2016.02.28451.
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Figure 1. Comparison of cummulative sleep quality index 
between NDCKD and HD CKD groups.
Association of Sleep Duration and Blood Pressure
   As the sympathetic activity is reduced and the vagal 
tone is elevated during the NREM sleep (7), this study 
examined whether the average sleep duration per day is 
associated with the reduction of blood pressure. This study 
found that the short sleep duration (less than 5 hours per 
day) is associated with elevated diastolic blood pressure 
among the ND CKD groups (r=0.421, p<0.05). There is an 
observed trend that the diastolic blood pressure is higher 
in individuals with shorter daily sleep duration, despite the 
insignificant statistical difference (Figure 2). In contrast, 
there is no association of daily sleep duration with diastolic 
blood pressure in the HD CKD group.
Association of Habitual Sleep Efficiency and Platelet-to-
lymphocyte Ratio
Habitual sleep efficiency (HBE) is an estimate of effective 
sleep  time  versus  the  time  spent  of  getting sleep.  This 
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Figure 2. Comparison of diastolic blood pressure among ND 
CKD patients based on the daily sleep duration. 
ratio  represents  the  actual  sleep  instead  of  the  time spent 
in bed during 24 hours. To know whether the time spent on 
effective sleep is associated with the predictor of vascular 
outcome, this study investigated the association of between 
the HBE and platelet-to-lymphocyte ratio. In ND CKD 
group, habitual sleep efficiency was positively associated 
with platelet-to-lymphocyte ratio (r= 0.532, p<0.0001). 
Association between the Severity of Sleep Disturbance 
with Serum hs-CRP level and Monocyte-to-lymphocyte 
Ratio
A requirement to use sleep medication and whether the sleep 
disturbance deteriorates the daily function are among the 
determiner of sleep disturbance severity. To assess whether 
the severity of sleep disturbance affects the inflammatory 
states or vice versa, this study investigated the association 
between the requirement to use sleep medication and daily 
dysfunction with inflammatory markers. In HD group, 
a requirement to use sleep medication was negatively 
correlated with serum hs-CRP level (r=0.434, p=0.030) 
and monocyte-to-lymphocyte ratio (r=-0.410, p=0.042). 
However, a requirement to use sleep medication was 
not correlated with serum hs-CRP level neither mono-to-
lymphocyte ratio in ND CKD group. A daytime dysfunction 
was associated with serum hs-CRP level in both ND 
CKD (r=0.345, p=0.032) and HD CKD groups (r=0.452, 
p=0.023, Table 2). Neutrophil-to-lymphocyte ratio was also 
correlated with daytime dysfunction in ND CKD group 
(r=0.320, p=0.046, Table 2).
Association of Anthropometric Measurement with Sleep 
Disturbance
As the obstructive sleep apnea (OSA) is prevalent among 
individuals with obesity (14), this study examined whether 
higher PSQI score which represents poor sleep quality is 
associated with anthropometric features of obesity. We 
that bigger neck circumference is associated with sleep 
disturbance component of PSQI score among the ND CKD 
group (r=0.391, p=0.01). This study also showed a trend that 
participants with PSQI score > 5 has a higher BFP compared 
to participants with PSQI score of less than 5, despite the 
statistically non-significant different (Figure 3).
Discussion
This study showed that the poor sleepers were more prevalent 
among the HD CKD compared to the ND CKD group. The 
higher  cumulative  score  of  PSQI  which represents poorer 
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Table 2. Association between daytime dysfunction with hs-CRP level and 
neutrophil-to-lymphocyte ratio
r p -value r p -value
Serum hs-CRP 0.345 0.032 0.452 0.023
Neutrophil-to-lymphocyte ratio 0.32 0.046 - NS
Characteristic
ND CKD HD CKD
hs-CRP: high sensitivity C-reactive protein; NS: not significant.
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Figure 3. BFP comparison of CKD patients with PSQI score 
>5 and ≤5.
sleep quality was also found among participants in HD CKD 
compared to ND CKD patients. This result confirmed the 
previous finding that sleep disorder is more common in end-
stage renal disease  (ESRD) patients receiving hemodialysis 
therapy compared to patients with a mild decrease in kidney 
function.(15) The previously reported prevalence of poor 
sleep quality assessed using PSQI in hemodialysis patients 
ranges between 34-78% (16), which is in accordance with 
the prevalence in this study. 
 The deteriorating effect of sleep disturbance in 
aggravating cardiovascular risk may stem from its influence 
in blood pressure. In the Coronary Artery Risk Development 
in Young Adults (CARDIA) Sleep Study, the shorter sleep 
duration and low sleep maintenance associated with poor 
control of both systolic and diastolic blood pressure after 
5 years.(17) In this study, the short sleep duration was 
associated with higher diastolic blood pressure. There is 
also an observed trend that ND CKD patients with less 
than 5 hours of sleep per day have higher diastolic blood 
pressure. The oscillation between REM and NREM sleep 
drive the oscillation in plasma renin activity (PRA).(18) 
During the NREM sleep, both systolic and diastolic baseline 
decrease due to decreased PRA and increased vagal tone. 
A study in ESRD patients revealed that the hemodialysis 
patients failed to increase the cardiac vagal tone during the 
NREM sleep (19). 
 The link between poor sleep quality and elevated blood 
pressure in this study may also be linked to inflammation. The 
habitual sleep efficiency in this study was associated with 
platelet-to-lymphocyte ratio, a predictor of atherosclerosis 
and complicated hypertension.(20) The severity of sleep 
disturbance also associated with alteration of other markers 
of inflammation such as lymphocyte-to-monocyte and 
neutrophil-to-lymphocyte ratio. Although how the immune 
system participates in the regulation of sleep is not fully 
understood, several clues indicate that different kind of 
cytokines affects sleep architecture (21).  IL-1 and tumor 
necrosis factors (TNF) affect the acquisition of NREM 
sleep across different species including rat, mouse, monkey, 
cat, rabbit, and sheep regardless of the administration 
route.(21,22) Immune-reactive neurons for IL-1 and TNF 
in the hypothalamus, the hippocampus, and the brainstem 
are implicated in the regulation of sleep-wake behavior. 
Stimulation by TNF, IL-1, or IL-6 regulates the release of 
nitric oxide, serotonin and adenosine which tightly regulate 
sleep-wake cycle.(23) Since declining kidney function 
associated with chronic inflammation and oxidative stress 
(4,24), it is likely that dysregulation of cytokine secretion by 
immune system components in CKD alter the sleep-wake 
architecture and sleep quality.
 A previous study also showed that that poor sleep 
quality was correlated with higher inflammatory markers 
such as hs-CRP (25). Our study did not demonstrate the 
association of cumulative PSQI with increased serum hs-
CRP level, which might be due to the small sample. However, 
this study showed that hs-CRP level was associated with two 
components of PSQI which describe the severity of sleep 
disorders: a requirement to use medication and daytime 
dysfunction. 
 In the previous study, obesity was found among 
the most common risk for OSA.(14) This study showed 
the positive association between the sleep disturbance 
score of PSQI with neck circumference, accompanied by 
a trend of higher body fat percentage among participants 
with poor sleep characteristic. Among the characteristic 
of sleep disturbance that was documented using PSQI 
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questionnaire in this study is relevant to the symptom of 
OSA, including the uncomfortable breath, loud snore, 
and suddenly waking up in the middle of the sleep. This 
result indicates that the sleep disturbance among this study 
participant might be partly related to obesity. Additionally, 
this finding strengthens the established understanding about 
the negative impact of obesity along with increased risk for 
CVD, chronic inflammation, and type 2 diabetes mellitus.
(13,26)
 In viewing this result, several limitations such as the 
cross-sectional nature of this study and small size should 
be considered. The use of PSQI as an instrument of sleep 
assessment may result in widely different estimates of sleep 
disorders. However, the prevalence of poor sleeper in this 
study fell within the range of previous studies using PSQI 
as their sleep assessment instruments.(27,28)
Conclusion
In summary, our study confirmed the higher prevalence 
of poor sleeper among HD CKD compared to ND CKD 
patients and demonstrated the association of  characteristics 
of poor sleep quality with increased inflammatory markers. 
Thus, this result prompts practicing nephrologist to pay 
closer attention to sleep complaints in managing CVD risk 
factors in CKD.
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